Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Chronic Graft Versus Host Disease
Related studies linked through entity extraction aliases.
A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD
- Status
- RECRUITING
- Phase
- N/A
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
- Status
- RECRUITING
- Phase
- PHASE2
Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
- Status
- RECRUITING
- Phase
- PHASE2
Upfront Ruxolitinib for Chronic Graft-vs-host Disease
- Status
- TERMINATED
- Phase
- PHASE1
Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
- Status
- RECRUITING
- Phase
- PHASE2
Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)
- Status
- RECRUITING
- Phase
- NA
Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease
- Status
- RECRUITING
- Phase
- PHASE2
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
- Status
- RECRUITING
- Phase
- PHASE2
Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
- Status
- SUSPENDED
- Phase
- PHASE1
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2